High-Volume Hemofiltration in Sepsis and SIRS: Current Concepts and Future Prospects

被引:55
作者
Honore, Patrick M. [1 ]
Joannes-Boyau, Olivier [3 ]
Boer, Willem [4 ]
Collin, Vincent [2 ]
机构
[1] St Pierre Para Univ Hosp, BE-1340 Ottignies, Belgium
[2] European Hosp St Michel, Brussels, Belgium
[3] Univ Bordeaux 2, Haut Leveque Univ Hosp Bordeaux, Pessac, France
[4] Atrium Med Ctr, Heerlen, Netherlands
关键词
Hemofiltration; Sepsis; Acute kidney injury; High-volume hemofiltration; Continuous renal replacement therapy; Dialysis; Systemic inflammation response syndrome; ACUTE-RENAL-FAILURE; CONTINUOUS VENOVENOUS HEMOFILTRATION; CRITICALLY-ILL PATIENTS; ACUTE KIDNEY INJURY; MULTIPLE ORGAN DYSFUNCTION; EXTRACORPOREAL BLOOD PURIFICATION; HIGH-FLUX HEMODIALYSIS; SEPTIC SHOCK; REPLACEMENT THERAPY; IMPROVES HEMODYNAMICS;
D O I
10.1159/000210031
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
In recent years, a number of techniques have been studied and developed in the field of renal replacement therapy in the septic patient. Manipulation of ultrafiltrate dose, membrane porosity, mode of clearance, and combinations of techniques have yielded promising findings. However, at present, conclusive evidence based on well-designed, randomized controlled trials remains scarce, limiting the practical implementation of many techniques in daily practice outside the context of a study. From the few well-designed and documented studies that we have so far, it is safe to say that optimalization of delivered dose in renal replacement therapy has a proven positive effect. An ultrafiltration rate between 35 and 45 ml/kg/h, with adjustment for predilution and down time, can be recommended for the septic patient until other data are available. The results of further dose outcome studies with higher ultrafiltration rates will likely be the stepping stone to further improvements in daily clinical practice. Copyright (C) 2009 S. Karger AG, Basel
引用
收藏
页码:1 / 11
页数:11
相关论文
共 86 条
  • [1] *ANZICS CLIN TRIAL, AUGM VS NORM REN REP
  • [2] Elimination of piperacillin and tazobactam by renal replacement therapies with AN69 and polysulfone hemofilters:: Evaluation of the sieving coefficient
    Arzuaga, A.
    Isla, A.
    Gascon, A. R.
    Maynar, J.
    Corral, E.
    Pedraz, J. L.
    [J]. BLOOD PURIFICATION, 2006, 24 (04) : 347 - 354
  • [3] Acute renal failure - definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group
    Bellomo, R
    Ronco, C
    Kellum, JA
    Mehta, RL
    Palevsky, P
    [J]. CRITICAL CARE, 2004, 8 (04): : R204 - R212
  • [4] Extracorporeal blood treatment (EBT) methods in SIRS/sepsis
    Bellomo, R
    Honoré, P
    Matson, J
    Ronco, C
    Winchester, J
    [J]. INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS, 2005, 28 (05) : 450 - 458
  • [5] Coupled plasma filtration adsorption
    Bellomo, R
    Tetta, C
    Ronco, C
    [J]. INTENSIVE CARE MEDICINE, 2003, 29 (08) : 1222 - 1228
  • [6] The Acute Dialysis Quality Initiative II: The Vicenza Conference
    Bellomo, R
    Kellum, JA
    Mehta, R
    Palevsky, PM
    Ronco, C
    [J]. ADVANCES IN RENAL REPLACEMENT THERAPY, 2002, 9 (04): : 290 - 293
  • [7] BELLOMO R, 2005, ADQI 3 C EL SUPPL MA
  • [8] Hemofiltration in sepsis and systemic inflammatory response syndrome: The role of dosing and timing
    Bouman, Catherine S. C.
    Straaten, Heleen M. Oudemans-van
    Schultz, Marcus J.
    Vroom, Margreeth B.
    [J]. JOURNAL OF CRITICAL CARE, 2007, 22 (01) : 1 - 12
  • [9] Effects of early high-volume continuous venovenous hemofiltration on survival and recovery of renal function in intensive care patients with acute renal failure: A prospective, randomized trial
    Bouman, CSC
    Oudemans-van Straaten, HM
    Tijssen, JGP
    Zandstra, DF
    Kesecioglu, J
    [J]. CRITICAL CARE MEDICINE, 2002, 30 (10) : 2205 - 2211
  • [10] BOUMAN CSC, 2006, NETH J CRIT CARE, V10, P561